Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.
Sign up for the Good Day BIO Newsletter >
June 3-6, 2024 | San Diego, CA BIO is where business and breakthroughs converge.
April 17-18, 2024 Washington, DC
July 24-28, 2024 Taipei, Taiwan
October 15-16, 2024 San Francisco, CA
Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.
Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.
Bringing you daily news at the intersection of biotechnology, politics, patients & the planet.
David (Dave) Lawrence Chief Business Officer Neurotrauma Sciences, LLC. Alpharetta, GA
Mike Knievel Sr. Director, Procurement Gilead Sciences Foster City, CA
Robert Freeberg Senior Director, Procurement Sangamo Therapeutics, Inc. Richmond, CA
Michelle Charpentier Head of Tech Ops Global Procurement BioMarin Pharmaceutical Inc. Novato, CA
Lynn M. Cilinski Vice President, Controller & Treasurer MacroGenics, Inc. Rockville, MD
Nicol Godfrey Director, Procurement Operations Exelixis Alameda, CA
Pat Magnafichi
Alameda, CA
Ryan Stoeckel Associate Director, Procurement Verve Therapeutics Cambridge, MA
